TELO2
Basic information
Region (hg38): 16:1493344-1510457
Links
Phenotypes
GenCC
Source:
- TELO2-related intellectual disability-neurodevelopmental disorder (Supportive), mode of inheritance: AR
- TELO2-related intellectual disability-neurodevelopmental disorder (Strong), mode of inheritance: AR
- TELO2-related intellectual disability-neurodevelopmental disorder (Definitive), mode of inheritance: AR
- TELO2-related intellectual disability-neurodevelopmental disorder (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
You-Hoover-Fong syndrome | AR | Cardiovascular | The condition can involve congenital cardiac anomalies, and awareness may allow early management | Cardiovascular; Craniofacial; Musculoskeletal; Neurologic | 27132593 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (433 variants)
- Inborn_genetic_diseases (173 variants)
- TELO2-related_intellectual_disability-neurodevelopmental_disorder (32 variants)
- TELO2-related_disorder (18 variants)
- not_specified (10 variants)
- Microcephaly (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TELO2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000016111.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 147 | 11 | 160 | |||
missense | 228 | 32 | 11 | 281 | ||
nonsense | 6 | |||||
start loss | 1 | 1 | ||||
frameshift | 11 | |||||
splice donor/acceptor (+/-2bp) | 8 | |||||
Total | 12 | 21 | 233 | 179 | 22 |
Highest pathogenic variant AF is 0.000180755
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TELO2 | protein_coding | protein_coding | ENST00000262319 | 20 | 17114 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
7.20e-14 | 0.833 | 125677 | 0 | 68 | 125745 | 0.000270 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.367 | 568 | 544 | 1.04 | 0.0000379 | 5237 |
Missense in Polyphen | 105 | 117.32 | 0.89499 | 1314 | ||
Synonymous | -1.95 | 294 | 254 | 1.16 | 0.0000184 | 1838 |
Loss of Function | 1.93 | 27 | 40.2 | 0.672 | 0.00000209 | 424 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000426 | 0.000392 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.000981 | 0.000925 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000289 | 0.000273 |
Middle Eastern | 0.000981 | 0.000925 |
South Asian | 0.000296 | 0.000294 |
Other | 0.000178 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Regulator of the DNA damage response (DDR). Part of the TTT complex that is required to stabilize protein levels of the phosphatidylinositol 3-kinase-related protein kinase (PIKK) family proteins. The TTT complex is involved in the cellular resistance to DNA damage stresses, like ionizing radiation (IR), ultraviolet (UV) and mitomycin C (MMC). Together with the TTT complex and HSP90 may participate in the proper folding of newly synthesized PIKKs. Promotes assembly, stabilizes and maintains the activity of mTORC1 and mTORC2 complexes, which regulate cell growth and survival in response to nutrient and hormonal signals. May be involved in telomere length regulation. {ECO:0000269|PubMed:12670948, ECO:0000269|PubMed:20810650}.;
- Disease
- DISEASE: You-Hoover-Fong syndrome (YHFS) [MIM:616954]: A syndrome characterized by severe global developmental delay, intellectual disability, dysmorphic facial features, microcephaly, abnormal movements, congenital heart disease comprising developmental abnormalities of the great vessels, and abnormal auditory and visual function. The transmission pattern is consistent with autosomal recessive inheritance. {ECO:0000269|PubMed:27132593}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Fanconi anemia pathway - Homo sapiens (human);mTOR signaling pathway - Homo sapiens (human);Steatosis AOP
(Consensus)
Recessive Scores
- pRec
- 0.108
Intolerance Scores
- loftool
- 0.217
- rvis_EVS
- 0.42
- rvis_percentile_EVS
- 76.68
Haploinsufficiency Scores
- pHI
- 0.281
- hipred
- Y
- hipred_score
- 0.743
- ghis
- 0.524
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.643
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Telo2
- Phenotype
- homeostasis/metabolism phenotype; cellular phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- telomere maintenance;regulation of TOR signaling;protein stabilization;positive regulation of protein serine/threonine kinase activity;positive regulation of TORC1 signaling;positive regulation of TORC2 signaling
- Cellular component
- nuclear chromosome, telomeric region;nucleus;cytoplasm;cytosol;membrane;nuclear body;TORC1 complex;TORC2 complex;nuclear periphery;ASTRA complex
- Molecular function
- protein binding;protein kinase binding;protein-containing complex scaffold activity;telomeric DNA binding;protein-containing complex binding;Hsp90 protein binding